Grail (NASDAQ:GRAL) Sees Strong Trading Volume – What’s Next?

Shares of Grail, Inc. (NASDAQ:GRAL) saw unusually-high trading volume on Tuesday . Approximately 945,734 shares were traded during trading, a decline of 26% from the previous session’s volume of 1,280,710 shares.The stock last traded at $61.89 and had previously closed at $55.02.

Analyst Ratings Changes

GRAL has been the subject of a number of recent research reports. Morgan Stanley initiated coverage on Grail in a report on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 price objective for the company. Wolfe Research assumed coverage on Grail in a report on Friday, November 15th. They issued a “peer perform” rating for the company.

Grail Stock Down 14.2 %

The firm has a fifty day moving average price of $24.61 and a 200-day moving average price of $18.40.

Hedge Funds Weigh In On Grail

Several institutional investors have recently bought and sold shares of the company. Crcm LP purchased a new position in Grail in the fourth quarter valued at approximately $65,061,000. Sessa Capital IM L.P. purchased a new position in Grail in the fourth quarter valued at approximately $53,550,000. Primecap Management Co. CA purchased a new position in Grail in the fourth quarter valued at approximately $37,118,000. Baker BROS. Advisors LP purchased a new position in Grail in the fourth quarter valued at approximately $29,098,000. Finally, Vanguard Group Inc. purchased a new position in Grail in the fourth quarter valued at approximately $25,902,000.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.